Cargando…
Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes
BACKGROUND: Several type B adverse drug reactions (ADRs), especially severe cutaneous adverse reactions (SCARs), are associated with particular human leukocyte antigen (HLA) genotypes. However, pre‐stored HLA information obtained from other clinical workups has not been used to prevent ADRs. We aime...
Autores principales: | Lee, Kye Hwa, Kang, Dong Yoon, Kim, Hyun Hwa, Kim, Yi Jun, Kim, Hyo Jung, Kim, Ju Han, Song, Eun Young, Yun, James, Kang, Hye‐Ryun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760506/ https://www.ncbi.nlm.nih.gov/pubmed/35070271 http://dx.doi.org/10.1002/clt2.12098 |
Ejemplares similares
-
Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018) -
Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry
por: Oh, Hea Lin, et al.
Publicado: (2019) -
Epidermiology of adverse drug reactions (ADRs) in the elderly
por: Ju-Young, Kim, et al.
Publicado: (2014) -
Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020) -
Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea
por: Yang, Min-Suk, et al.
Publicado: (2019)